India-based CRO enters US market to support global research

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/dk_photos)
(Image: Getty/dk_photos)

Related tags: CRO, Clinical trials, Lambda Therapeutic Research, Novum Pharmaceutical Research Services

Lambda Therapeutic Research is extending its global footprint to the US with the acquisition of Novum Pharmaceutical Research Services, a CRO based in Pittsburgh, PA.

While Lambda’s first US-based facility, Novum will be the company’s second in North America following its 2010 acquisition of Biovail’s R&D facilities in Canada. The India-headquartered contract research organization (CRO) also has offices in Poland and the UK.

Following the transaction, Novum will retain its identity and operate as a division of Lambda led by CEO Christopher Chamberlain, who will manage US operations.

The deal – which Chamberlain called “a powerful strategic move between two like-minded CROs with many years of experience” – ​also marks Lambda’s entrance into the US market

“There will also be a wide array of high-quality services under one umbrella that will greatly benefit customers. Both companies have extensive experience with early and late phase research, but specialize in somewhat complementary niches,”​ he told us.

“The combined company will allow clients to conduct many types of late phase research on a global scale, pursue large molecule and highly complex trials, including 505(b)(2) programs, patient studies, and topical and transdermals,”​ added Chamberlain.

Clients also will have access to bioanalytical capabilities, pharmacovigilance, and imaging services.

As per integration, Chamberlain said all plans are in active development as the companies close the transaction, financial terms of which have not been disclosed.

Related news

Show more

Related products

show more

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 18-Apr-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us


View more